Research could unlock more precise prognoses and targeted treatments for children with cancer
Date:
A new neuroblastoma study has identified distinct subgroups in the disease which could help improve prognosis and therapy.
A recent study published in the British Journal of Cancer identified three new subgroups of the most common type of neuroblastoma, a childhood cancer. This knowledge offers a more nuanced understanding of neuroblastoma variations and suggests pathways for more targeted treatments.
Conducted by researchers from the University of Southampton and China, the study examined over 1,500 biopsy samples from 16 datasets, revealing three distinct subtypes within neuroblastomas. Each subgroup displayed unique genetic traits, expected outcomes, and potential treatment responses, providing clues for improved prognosis and precision therapy.
This breakthrough offers new avenues for personalised medicine in the treatment of neuroblastomas, potentially improving outcomes and quality of life for affected children.
To find out more about this story, click here
